Myeloid Cell Interaction with HIV: A Complex Relationship
- PMID: 29250073
- PMCID: PMC5714857
- DOI: 10.3389/fimmu.2017.01698
Myeloid Cell Interaction with HIV: A Complex Relationship
Abstract
Cells of the myeloid lineage, particularly macrophages, serve as primary hosts for HIV in vivo, along with CD4 T lymphocytes. Macrophages are present in virtually every tissue of the organism, including locations with negligible T cell colonization, such as the brain, where HIV-mediated inflammation may lead to pathological sequelae. Moreover, infected macrophages are present in multiple other tissues. Recent evidence obtained in humanized mice and macaque models highlighted the capacity of macrophages to sustain HIV replication in vivo in the absence of T cells. Combined with the known resistance of the macrophage to the cytopathic effects of HIV infection, such data bring a renewed interest in this cell type both as a vehicle for viral spread as well as a viral reservoir. While our understanding of key processes of HIV infection of macrophages is far from complete, recent years have nevertheless brought important insight into the uniqueness of the macrophage infection. Productive infection of macrophages by HIV can occur by different routes including from phagocytosis of infected T cells. In macrophages, HIV assembles and buds into a peculiar plasma membrane-connected compartment that preexists to the infection. While the function of such compartment remains elusive, it supposedly allows for the persistence of infectious viral particles over extended periods of time and may play a role on viral transmission. As cells of the innate immune system, macrophages have the capacity to detect and respond to viral components. Recent data suggest that such sensing may occur at multiple steps of the viral cycle and impact subsequent viral spread. We aim to provide an overview of the HIV-macrophage interaction along the multiple stages of the viral life cycle, extending when pertinent such observations to additional myeloid cell types such as dendritic cells or blood monocytes.
Keywords: antiretroviral therapy; macrophages; reservoir; restriction factors; sensing; viral assembly; virus-containing compartment.
Figures
Similar articles
-
The Role of Macrophages in HIV-1 Persistence and Pathogenesis.Front Microbiol. 2019 Dec 5;10:2828. doi: 10.3389/fmicb.2019.02828. eCollection 2019. Front Microbiol. 2019. PMID: 31866988 Free PMC article. Review.
-
Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells.Virology. 1996 Dec 15;226(2):205-16. doi: 10.1006/viro.1996.0648. Virology. 1996. PMID: 8955040
-
HIV-1 assembly in macrophages.Retrovirology. 2010 Apr 7;7:29. doi: 10.1186/1742-4690-7-29. Retrovirology. 2010. PMID: 20374631 Free PMC article. Review.
-
The macrophage and HIV: basic concepts and methodologies.Methods Mol Biol. 2014;1087:207-20. doi: 10.1007/978-1-62703-670-2_17. Methods Mol Biol. 2014. PMID: 24158825
-
Reduced Simian Immunodeficiency Virus Replication in Macrophages of Sooty Mangabeys Is Associated with Increased Expression of Host Restriction Factors.J Virol. 2015 Oct;89(20):10136-44. doi: 10.1128/JVI.00710-15. Epub 2015 Jul 22. J Virol. 2015. PMID: 26202248 Free PMC article.
Cited by
-
HIV-1 persistence in the CNS: Mechanisms of latency, pathogenesis and an update on eradication strategies.Virus Res. 2021 Oct 2;303:198523. doi: 10.1016/j.virusres.2021.198523. Epub 2021 Jul 24. Virus Res. 2021. PMID: 34314771 Free PMC article. Review.
-
The Balance between p53 Isoforms Modulates the Efficiency of HIV-1 Infection in Macrophages.J Virol. 2021 Sep 27;95(20):e0118821. doi: 10.1128/JVI.01188-21. Epub 2021 Aug 11. J Virol. 2021. PMID: 34379507 Free PMC article.
-
Role of microglia in HIV-1 infection.AIDS Res Ther. 2023 Mar 16;20(1):16. doi: 10.1186/s12981-023-00511-5. AIDS Res Ther. 2023. PMID: 36927791 Free PMC article. Review.
-
Current and Future Therapeutic Strategies for Lentiviral Eradication from Macrophage Reservoirs.J Neuroimmune Pharmacol. 2019 Mar;14(1):68-93. doi: 10.1007/s11481-018-9814-5. Epub 2018 Oct 13. J Neuroimmune Pharmacol. 2019. PMID: 30317409 Free PMC article. Review.
-
The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency.Front Immunol. 2021 Aug 31;12:720697. doi: 10.3389/fimmu.2021.720697. eCollection 2021. Front Immunol. 2021. PMID: 34531866 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
